When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CPRX - Catalyst Pharmaceuticals Inc.: Attractive Value Supported By New Growth Opportunities
Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals reported its Q4 results highlighted by record revenues from its Firdapse drug, as the only FDA-approved treatment of LEMS disease.
The company expects momentum to continue with the end of the pandemic allowing for new patients to be diagnosed and receive a prescription.
Overall, solid fundamentals including recurring profitability, steady revenue profile, and new growth opportunities at an attractive valuation keep us bullish.